Success Story

Johns Hopkins Singapore

Johns Hopkins Singapore, established in 1999, has become an academic division of the Johns Hopkins School of Medicine.  The new Division of Johns Hopkins in Singapore follows the academic model of the School of Medicine, and will have the same rights and privileges as the other departments and divisions.

With this change in status, also comes a new grant issued by Singapore’s Agency for Science Technology and Research (A*STAR). This new 5-year grant of S$75 million (US$43 million) is to fund research initiatives in the areas of immunology, virology and the related sub disciplines, as well as to train bright young scientists in these fields. 

Additionally, the Division looks forward to its move to Biopolis ~a state-of-the-art biotech park built by the Singapore government.  The Biopolis is designed to be a leading Asian center for biomedical sciences research and development where several key government agencies, publicly funded research institutes, and R&D laboratories of pharmaceutical and biotech companies will be located.

Johns Hopkins Singapore embarked upon its first Graduate Training Program in Molecular and Cellular Immunity in July 2003.  This program is being carried out in partnership with the National University of Singapore Faculty of Medicine Graduate Research Program.  Part of the Division’s new educational initiatives will be to expand its Graduate Training Programs and award Hopkins’ degrees in the fields of Biomedical Engineering, Clinical Investigation and Immunology.

Our scientists continue to excel and contribute valuably to the research field by way of publications in high impact journals, presentations at meetings and conferences both locally and internationally as well as filing patents.  The scientists work closely with both their peers in Baltimore as well as other collaborators in Singapore.

To learn more about Johns Hopkins Singapore, please visit  www.jhs.jhmi.edu